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A B S T R A C T   
We previously found that surface topographies induce the expression of the Scxa gene, encoding Scleraxis in 
tenocytes. Because Scxa is a TGF-β responsive gene, we investigated the link between mechanotransduction and 
TGF-β signaling. We discovered that mesenchymal stem cells exposed to both micro-topographies and TGF-β2 
display synergistic induction of SMAD phosphorylation and transcription of the TGF-β target genes SCX, a-SMA, 
and SOX9. Pharmacological perturbations revealed that Rho/ROCK/SRF signaling is required for this synergistic 
response. We further found an activation of the early response genes SRF and EGR1 during the early adaptation 
phase on micro-topographies, which coincided with higher expression of the TGF-β type-II receptor gene. Of 
interest, PKC activators Prostratin and Ingenol-3, known for inducing actin reorganization and activation of 
serum response elements, were able to mimic the topography-induced TGF-β response. These findings provide 
novel insights into the convergence of mechanobiology and TGF-β signaling, which can lead to improved culture 
protocols and therapeutic applications.   
1. Introduction 
Under physiological conditions, tissue homeostasis is maintained by 
the appropriate spatio-temporal responses of cells to environmental 
signals, such as secreted cytokines and transmembrane proteins from 
adjacent cells, but also by mechanical forces and changes in cell shape 
[1]. The latter is evident by the secretion and autocrine activity of 
insulin-like growth factor (IGF) by myocytes upon mechanical stimula-
tion, a potent growth factor that induces muscle growth [2]. Similarly, 
tendon tissue homeostasis and growth depends on both mechanical 
forces [3] and transforming growth factor (TGF-β) signaling [4]. Also, 
the myofibroblastic state during tissue repair depends both on the me-
chanical characteristics of the matrix environment as well as the pres-
ence of TGF-β [5]. During embryonic development, mechanical forces 
are essential for proper morphogenesis in conjunction with biochemical 
signals, as shown by the spatial reorganization of TGF-β receptors upon 
cell confinement in gastruloids [6]. Mechanical forces can rapidly acti-
vate various intracellular signaling pathways [7]. Well-documented 
examples include the activation of the transcription factors 
yes-associated protein 1 (YAP), and transcriptional coactivator with 
PDZ-binding motif (TAZ) through stretching [8] and cell shape changes 
[9]. These transcription factors are essential for tissue homeostasis and 
embryogenic processes [10,11], such as osteogenesis [12], which is also 
influenced by bone morphogenetic protein 2 (BMP-2) [13]. Changes in 
actin dynamics influence serum response factor (SRF) activity through 
altered binding with co-transcription factors [14], leading to broad 
changes in physiological processes [15,16], including myofibroblast 
differentiation [17] which in turn can be regulated through TGF-β 
signaling [18]. How these mechanical and biochemical signals converge 
to drive cell behavior is poorly understood. Therefore, gaining novel 
insights in these mechanisms is vital for developing therapeutics in case 
of improper cell function and tissue engineering applications. 
Since it is difficult to decouple the effects of biochemical and me-
chanical stimuli in vivo, essential insights are gained by in vitro experi-
ments. Here, physical cues relayed through altered surface geometry can 
offer mechanical stimulation through changing cell shape. Cell geome-
try profoundly affects cell behavior, as shown by altering the lineage 
specification of stem cells [19–21]. Evidence exists that cell geometry 
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also influences the biological effects of soluble factors. For example, 
adhesive islands alter the genomic response after tumor necrosis factor 
(TNF)α stimulation [22], and growth factor signaling from BMP-2 [23] 
or serum [24]. Also, cell confinement through micro-wells reduces the 
inflammatory response to lipopolysaccharide (LPS) in macrophages 
[25]. Of interest here is that surprisingly little is known how surface 
topography controls the cell’s response towards growth factor signaling. 
This is an important consideration since growth factors are involved in 
numerous biological processes, including differentiation [26] and 
maintenance of phenotypic identity [27]. Research involving cell 
stretching hints towards an interesting interplay between biomechanical 
forces and soluble factors. For example, cell stretching increases the 
sensitivity for soluble factors through altering receptor expression or 
activity [28–30]. In this manuscript, we provide new insights in this 
field by demonstrating that topographical cues alter the response of 
mesenchymal stem cells (MSCs) to TGF-β signaling. 
2. Results 
2.1. MSCs cultured on micro-topographies display altered actin dynamics 
and differential expression of cytoskeletal genes 
An eye-catching characteristic of cells cultured on surface structures 
are profound changes in cell morphology [21,31]. This is demonstrated 
Figure 1. MSCs cultured on micro-topographies display altered actin organization and differential expression of cytoskeletal genes. A) In silico design of the 
PS-281 micro-topographical surface. Scale bar represent 10 μm. B) MSCs cultured on a regular PS flat surface exhibit spread morphological characteristics and a 
profound presence of F-actin stress fibers. C) MSCs cultured on surface PS-281 exhibit elongated and smaller nuclear and cellular characteristics, which coincides 
with a reduction of F-actin stress fibers. F-actin was immunolabeled with phalloidin (yellow) and the nucleus counterstained with Hoechst33342 (magenta). Scale 
bars represent 50 μm. D) Partial representation of a STRING gene network based on a microarray study of MSCs cultured on the PS-281 surface for 24 h. The 
mechanosensitive transcription factors EGR1, FOS, and FOSB are represented here. E) EGR1, FOS, and FOSB expression levels have increased 2–5 fold on the PS-281 
surface compared to a flat surface (***P < 0.001). F) Volcano plot representation of the PS-281 microarray data. Blue dots are probe targets associated with 
cytoskeletal organization. Majority of these DEGs exhibit lower expression levels compared to flat. DEG cut-off is determined at a 1.5 fold change and an adjusted P 
value of 0.05. 
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when seeding adipose-derived MSCs on micro-topography PS-281, 
which is a geometrically designed surface structure of 10 μm height and 
length along its longest axis (Fig. 1A and Supplementary Fig. 1). After 
24 h of cell culture, these micro-topographies greatly reduce the cell and 
nuclei size of MSCs compared to a standard flat surface culture (Fig. 1B 
and C). Furthermore, these changes in morphology are accompanied by 
a reduction of filamentous(F)-actin stress fibers, with the cytoskeleton 
obtaining elongated characteristics in between the structures. We pre-
viously assessed the transcriptome of bone marrow-derived MSCs on 
surface PS-281 relative to MSCs on flat control surfaces (under review) 
and produced a STRING protein-protein interaction network with 248 
nodes and 1839 edges based on differentially expressed genes (DEGs) 
with a fold change higher than 1.5, lower than − 1.5, and an adjusted 
p-value smaller than 0.05. To assess how micro-topographies elicit a 
biomechanical response, we screened the DEGs for mechanosensitive 
transcription factors and found an upregulation of early growth response 
gene 1 (EGR1) (3.0 fold change), FBJ murine osteosarcoma viral onco-
gene homolog (FOS) (4.7 fold change), and FOSB (2.2 fold change) 
(Fig. 1D and E) [32]. We next produced a volcano plot of genes with 
Gene Ontology (GO) term “cytoskeleton organization”, and noticed that 
many cytoskeleton related DEGs exhibit lower expression when cultured 
on surface PS-281, with a total of 48 DEGs downregulated and 11 DEGs 
upregulated (Fig. 1F and Supplementary Tables 1–2). Downregulated 
genes are involved in microtubule dynamics, e.g., stathmin 1 (STMN1; 
− 1.6 fold change), an important cytoskeletal effector regulating 
microtubule dynamics [33], tubulin β class I (TUBB; − 1.9 fold change), 
tubulin β 4B class IVb (TUBB4B; − 1.8 fold change), tubulin α 1a 
(TUBA1A; − 1.8 fold change), and tubulin β 6 class V (TUBB6; − 1.6 fold 
change). Other genes such as actin γ-1 (ACTG1; − 1.9 fold change) and 
tropomyosin 3 (TPM3; − 1.7 fold change) form integral parts of the 
cytoskeleton [34]. Of interest, we also observed a slight downregulation 
of actin β (ACTB; − 1.3 fold change). We further found a reduction in 
expression levels of genes associated with small GTPase rho signal 
transduction and subsequent cytoskeletal organization [35] (Supple-
mentary Fig. 2). For example, we detected a downregulation of ezrin 
(EZR; − 1.9 fold change), an actin-binding protein that acts as a linker 
between the actin cytoskeleton and plasma membrane proteins [36], 
and positively modulates rho signaling through the interaction with rho 
GDP dissociation inhibitors [37]. A downregulation was observed for 
diaphanous related formin 3 (DIAPH3; − 1.5 fold change), which is 
required for F-actin stress fiber formation [38] and regulates SRF ac-
tivity [39]. We also mention the downregulation of anillin actin-binding 
protein (ANLN; − 1.7 fold change), which is important for cytoskeletal 
dynamics [40] and is involved in rho signaling [41]. The gene signature 
induced by surface PS-281 demonstrates that the cytoskeleton is under a 
lot of change 24 h after cell seeding, which corresponds with the visual 
observed alterations in cytoskeleton architecture and cell geometry. 
2.2. Activation of early response genes is associated with early actin 
reorganization 
Based on the observed increased expression of FOS and EGR1 at 24 h, 
we decided to investigate actin organization dynamics and the expres-
sion of early genes and proteins with a known relation to actin remod-
eling on surface PS-1018, which we previously discovered as a surface 
that induces Scleraxis (Scx), and EGR1 expression in tenocytes [42]. 
Furthermore, PS-1018 can be manufactured in a 100 mm dish format for 
each fabricated sheet, which is not the case for surface PS-281 that only 
could be manufactured in 15 mm format, thereby facilitating further 
experiments. Analogous as surface PS-281, PS-1018 has a height profile 
of 10 μm, yet differs in size with a 20 μm length along its longest axis. 
Surface PS-1018 (Fig. 2A and Supplementary Fig. 3) induced cell elon-
gation with a profound reduction in cell and nuclear size, while reducing 
actin stress fibers (Fig. 2B), similar to surface PS-281. As early as 1 h 
after cell seeding, we noted that cells on flat surfaces exhibited a diffuse 
actin pattern with a round cell morphology (Fig. 2C); however, MSCs 
adhering on the surface PS-1018 displayed different dynamics. Here, 
MSCs engulfed the micro-topographies with concentrated F-actin stress 
fiber formation on top of the structures (Fig. 2D), but a more diffuse 
actin pattern at the bottom and in between the structures (Fig. 2E). 
Quantification of F-actin levels showed significantly elevated F-actin 
levels at 1 h and 2 h on PS-1018, with levels peaking at 1 h and dropping 
afterwards (Supplementary Figs. 4A–B). To probe the early regulatory 
responses, we exposed MSCs cultured for 2 h to flat and surface PS-1018 
and analyzed the phospho-proteome by mass spectrometry (Supple-
mentary Fig. 5). We detected increased levels of phosphorylated actin in 
cells cultured on surface PS-1018, indicating active cytoskeletal reor-
ganization [43,44]. Also, we detected increased levels of phosphory-
lated adenylyl cyclase-associated protein 1 (CAP-1) and drebrin 1 
(DBN1), which regulate actin dynamics [45,46]. These observations 
indicate that MSCs cultured on the micro-topography are subjected to 
dynamic cytoskeletal regulation, characterized by an early adaptation 
phase involving actin remodeling. 
We next investigated genes and proteins, of which it is known that 
their expression or activity is influenced by actin. First, we observed a 
3.6 fold increase in EGR1 mRNA levels compared to flat at 24 h and no 
significant difference at 48 h (Fig. 2F). At earlier time points, we 
assessed EGR1 protein expression dynamics on both flat and PS-1018 
(Fig. 2G). At 2 h, we found increased EGR1 levels in the nucleus when 
MSCs are cultured on PS-1018 compared to flat (Fig. 2H). Of interest, we 
measured a slight yet non-significant increase at 24 h. This seemingly 
contradicts the qPCR and microarray observations on surface PS-281; 
however, we believe this to be caused by a subpopulation of cells with 
high EGR1 levels on the PS-1018 surface that skews the global EGR1 
levels measured on RNA level. Equally interesting was the observation 
that after 2 h, EGR1 levels on a flat surface was higher than on flat and 
the PS-1018 surface at 24 h. We contribute this phenomenon to cell- 
seeding that induces a biomechanical response. 
Next, we explored if we could detect alterations in SRF levels after 2 
h and 24 h on PS-1018 (Fig. 2I). SRF is an important transcription factor 
that is associated with changes in actin dynamics [41] and known for 
inducing transcription of genes with serum response elements in its 
promoter, which includes FOS, EGR1, and SRF itself [47,48]. Similar to 
EGR1, high intensities of nuclear SRF were observed at 2 h (Fig. 2J), 
followed by a slight yet non-significant decrease at 24 h compared to the 
flat surface. 
2.3. Micro-topographical cues elevate TGF-βR-II and SCX levels in MSCs 
EGR1 elevation on surface PS-1018 is interesting, considering that 
EGR1 is involved in the expression of the tendon-specific transcription 
factor scleraxis (SCX) [49,50], which in previous work was induced in 
tenocytes on micro-topographies [42]. It is unclear how EGR1 influences 
SCX but considering that SCX is upregulated in response to TGF-β [26], 
evidence exists that this is through increased expression of the TGF-β2 
ligand [51] or the transforming growth factor-β type II receptor 
(TGF-βR-II) [52]. Browsing of the PS-281 transcriptomics data set for 
TGF-β signaling revealed five genes with a significant fold change of 
more than 1.5 associated with GO biological process “Response to 
TGF-β” (Fig. 3A). These include the previously mentioned FOS gene (4.6 
fold change), known for participating with small mothers against 
decapentaplegic (SMAD) proteins to influence TGF-β signaling [53]. 
Also, an upregulation was observed for the TGF-β inducible genes 
collagen-III (COL-III; 1.6 fold change) [54], prostate transmembrane 
protein androgen-induced 1 (PMEPA1; 1.5 fold change) [55], and matrix 
remodeling-associated protein 5 (MXRA5; 1.5 fold change) [56]. We 
also noted a downregulation of neuronal regeneration related protein 
(NREP; − 1.5 fold change), which is related to an expression decrease of 
the growth factors TGF-β1 and TGF-β2 [57]. In addition, we noticed an 
increase in SMAD7 expression (1.41 fold change), an antagonist of the 
TGF-β/SMAD pathway that functions as a negative feedback activator 
after TGF-β signaling [58]. We also mention a 2.81 fold change increase 
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of VCAM1, which is TGF-β inducible [59], yet was not part of the GO list. 
Of interest, we also noted (through multiple probes) an upregulation 
of TGF-βR-II (1.9 and 2.0 fold change), an essential component of the 
TGF-β/SMAD signaling pathway. These findings strengthen the hy-
pothesis that micro-topographies sensitize MSCs for TGF-β related 
signaling. We confirmed increased TGF-βR-II expression on surface PS- 
1018 by qPCR after 8 h (Fig. 3B; 1.3 fold change), and reaching a 
maximum at 24 h (2.1 fold change). At 48 h, no significant differences in 
TGF-βR-II levels were detected between PS-1018 and flat. It is known 
that mitogen-activated protein kinase kinase (MEK) inhibitors, such as 
U0216, can inhibit the activation of its downstream target EGR1 [60, 
61], which we experimentally verified (Supplementary Fig. 6). Inter-
estingly, U0216 also decreased TGF-βR-II expression on the PS-1018 
surface. 
We further observed a 2.5 fold increase of the TGF-β inducible gene 
SCX after 8 h, with maximum SCX levels after 24 h (3.5 fold change), 
which decreased to 2.8 fold after 48 h. After 72 h, no significant SCX 
elevation was detected (Fig. 3C). We also found that U0216 reduced 
topography-induced SCX upregulation. These findings demonstrate that 
micro-topographies enhance SCX levels in MSCs, which could be guided 
by a general sensitization for TGF-β signaling through SRF, EGR1 and 
TGF-βR-II (Fig. 3D). 
2.4. Surface topography and TGF-β2 synergistically induce TGF-β target 
genes 
Given that SCX can be induced by both TGF-β2 [26] and topography 
[42], we investigated the combined effect of TGF-β2 and 
micro-topographies on TGF-β signaling. First, we measured SMAD2/3 
phosphorylation (P-SMAD) as an immediate response to TGF-β receptor 
signaling and mediator of TGF-β target gene expression. 24 h time after 
cell seeding, the timepoint with maximum TGF-βR-II expression, we 
exposed MSCs to TGF-β2 and fixed the cells 30 min after the treatment 
(Fig. 4A). Quantification of nuclear P-SMAD levels demonstrated that 
TGF-β2 treatment resulted in a 1.2 fold increase in nuclear P-SMAD 
levels compared to cells cultured on flat (Fig. 4B). Of interest, we 
observed that TGF-β2 treatment of MSCs grown on PS-1018 resulted in a 
1.7-fold increase in nuclear P-SMAD levels compared to non-treated 
cells. Next, we isolated the RNA of MSCs cultured on flat or PS-1018, 
treated with and without TGF-β2 between 4 h and seven days after 
cell seeding (Fig. 4C). The most striking and important observation we 
made is a synergistic induction of SCX expression at 24 h. Whereas SCX 
levels on PS-1018 were 3.5 fold higher compared to a regular flat sur-
face, TGF-β2 stimulation alone resulted in a 14.5 fold increase in SCX 
levels compared to flat. Of interest here is that the combined exposure of 
MSCs to PS-1018 and TGF-β2 induced SCX 39.9 fold. This synergy was 
already detected after 8 h, although at lower levels, and was observed 
during the whole seven days culture period. It is interesting to note that 
SCX expression declines over time, which could be related to the tran-
sient upregulation of the early response genes and TGF-βR-II. 
The synergistic response to TGF-β2 on surface PS-1018 was not 
unique to MSCs. We induced a similar biological response in human 
dermal fibroblasts and C3H10T1/2 cells, a mouse mesenchymal-like cell 
line that is frequently utilized in differentiation studies (Fig. 4D). These 
findings demonstrate that the synergy between TGF-β signaling and 
surface topography is reproducible in multiple TGF-β2-response cell 
Figure 2. Micro-topographies elevate the early response genes SRF and EGR1 during the cells early adaptation phase. A) In silico design of the PS-1018 
surface used in subsequent experiments. Scale bar represent 10 μm. B) Similar as the PS-281 surface, the PS-1018 surface elicits smaller, elongated morpholog-
ical characteristics and a reduction in F-actin stress fibers. F-actin was immunolabeled by phalloidin (yellow) and the nucleus counterstained with Hoechst33342 
(magenta). Scale bar represent 50 μm. C) Immunolabeling of F-actin after 1 h of cell culture reveals that MSCs on a flat surface exhibit a spread morphology with a 
diffuse F-actin pattern. D-E) Immunolabeling of F-actin of MSCs cultured for 1 h on the PS-1018 surface reveals an increase in F-actin stress fibers concentrated on the 
upper part of the micro-topographical structures, while a diffuse pattern is observed at the bottom of the PS-1018 structures. Scale bar represent 10 μm. F) EGR1 
levels are elevated at 24 h as measured through qPCR (*P < 0.05), a similar observation as with the PS-281 microarray data. G-H) Immunolabeling of EGR1 
demonstrates elevated intensities on the PS-1018 surface at 2 h, with only a few cells on the PS-1018 surface showing elevated levels after 24 h. Quantification of 
EGR1 fluorescent signal confirms the visual observation, with elevated levels measured at 2 h (***P < 0.001), and no significant difference at 24 h. Scale bar 
represent 100 μm. I-J) Immunolabeling of SRF demonstrates elevated levels on the PS-1018 surface at 2 h (***P < 0.001), with no significant differences at 24 h. 
Barplot represent the mean with error bars representing SEM. Dotplots represent protein intensity levels in individual nuclei. Blue line indicates median. Scale bar 
represent 100 μm. 
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lines. Besides SCX, we also found a similar effect for other TGF-β 
responsive genes. Expression of α-SMA, a differentiation marker of 
smooth muscle cells and myofibroblasts [62], and the chondrogenic 
transcription factor SOX9 [63] can be induced by TGF-β2, and display a 
synergistic effect when combined with micro-topographies (Fig. 4E and 
F). These observations demonstrate that micro-topographies sensitize 
cells for TGF-β signaling. 
2.5. Rho/ROCK/SRF signaling is required for topography-induced TGF-β 
sensitization 
We next set out to investigate the signaling events that occur be-
tween surface topography-induced actin-mediated signaling and tran-
scriptional activation of TGF-β target genes, by investigating the 
synergistic effect in the presence of several small-molecule inhibitors of 
signal transduction (Fig. 5). We confirmed the synergy in the presence of 
DMSO, the diluent of the inhibitors used in the rest of the study (Fig. 6A), 
and validated that SCX gene expression is indeed dependent on TGF-β 
receptor activation, using its inhibitor SB431542 [64] (Fig. 6B). Inter-
estingly, this compound abolished SCX expression in MSCs on PS-1018 
alone, which indicates that even without the addition of TGF-β2, 
TGF-β/SMAD signaling is occurring. This may hint at auto- or paracrine 
signaling elicited by the MSCs, or TGF-β originating from the serum 
media. 
Next, we studied the effect of the Rho-associated protein kinase 
(ROCK) inhibitor Y27632, because Rho proteins influence numerous 
biological responses, including cell shape and actin cytoskeletal 
rearrangement [65] and are important for driving cell behavior of cells 
grown on physical cues. Y27632 did not affect the induction of SCX by 
TGF-β2 on flat control surfaces but did abolish the synergistic effect on 
the PS-1018 surface (Fig. 6C). Very similar results were obtained with 
CCG-203971, a compound which inhibits SRF/Myocardin Related 
Transcription Factor A (MRTF) gene transcription [66] (Fig. 6D) and 
blebbistatin (Fig. 6E), an inhibitor of non-muscle myosin-II [67] which 
prevents actin-myosin interaction resulting in subsequent disruption of 
actin dynamics [68]. Of interest, utilizing the MEK inhibitor U0216 did 
lower the level of SCX but did not abolish the synergistic effect (Fig. 6F), 
which indicates that the topography-induced mechanotransduction is 
not guided through MAPK signaling. These observations demonstrate 
that actin dynamics and the Rho/ROCK/SRF signaling pathway are 
necessary for micro-topographies to enhance the expression of SCX. 
2.6. PKC activators mimic topography-induced mechanotransduction 
Small molecules that inhibit actin-related signaling were able to 
block topographic induction of TGF-β2 signaling, so vice versa, it may be 
possible to mimic topographic mechanotransduction with small mole-
cules that mimic actin-related signaling. To find these molecules, we 
searched the Connectivity Map, a compendium of more than one million 
gene expression profiles induced by small molecules and genetic per-
turbations, which is used for determining similarities in gene expression 
profiles between these perturbations [69]. We previously described that 
topography-induced TGF-β2 signaling coincides with high levels of 
F-actin and concomitant SRF signaling after 1 h, but reduced F-actin and 
Figure 3. Micro-topographies induce elevated levels of TGF-βR-II and the TGF-β target gene SCX. A) Volcano plot of the PS-281 microarray with probe targets 
associated with TGF-β signaling represented in blue. DEG cut-off is determined at a 1.5 fold change and an adjusted P value of 0.05. Increased levels of TGF-βR-II are 
observed (1.9 and 2.0 fold increase; ***P < 0.001). B) qPCR of MSCs cultured on the PS-1018 surface validates the PS-281 observation regarding TGF-βR-II 
expression, with elevated levels observed at 8 h and 24 h. The ERK inhibitor U0216 inhibits the topography induced TGF-βR-II expression (*P < 0.05). C) The PS- 
1018 surface induces elevated levels of the TGF-β target gene SCX. Significant elevated levels were detected at 8 h, 24 h and 48 h (**P < 0.01), with a maximum 
expression at 24 h. In addition, the inhibitor U0216 abolishes topography-induced SCX expression. D) Schematic representation of the mechanism involving the 
activation of SRF and EGR1 leading to an upregulation of TGF-βR-II. Each asterisk represents statistical significance of SCX expression levels compared to a flat 
control condition. Barplots represent the mean with error bars representing SEM. 
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lower expression of genes related to Rho/ROCK/SRF signaling after 24 
h. We reasoned that topography mimicking small molecules should, 
therefore, recapitulate the actin dynamics observed on topographies. 
The Connectivity Map only contains gene expression data from later 
time points, and we therefore retrieved small molecules using the gene 
expression fingerprint of cells in which β-actin, SRF, and FOS genes were 
knocked down as bait for the search (Fig. 7A–C), because this best re-
flects the lower Rho/ROCK/SRF signaling axis after 24 h. Of interest, 
perturbagen class “Protein Kinase C (PKC) activators” was present in the 
lists of β-actin (ACTB), SRF, and FOS and thus resembles gene signatures 
associated with these knockdowns. Furthermore, in the list of PKC ac-
tivators, “MEK inhibitors” were present with a negative score, which 
could indicate a positive involvement for EGR1 (Fig. 7D). Also for 
tubulin, of which we see a decrease of multiple isoforms in the micro-
array data, we see an association with PKC activators (Supplementary 
Fig. 7), suggesting that treatment of cells with PKC activators leads to 
similar gene expression profiles as when ACTB, SRF, and FOS are 
knocked-down. 
PKC activators can induce actin reorganization [70], which eventu-
ally leads to a decrease in actin stress fibers [71]. Furthermore, they can 
activate FOS [72] and EGR1 [73]. This makes this perturbagen class an 
interesting candidate for molecules that can mimic topography-induced 
TGF-β sensitization (Fig. 7E). We want to mention that in the β-actin 
knockdown gene fingerprint list, we found gene signature resemblances 
with other perturbagens such as cytochalasin-B, a microtubule inhibitor, 
and cytochalasin-D, an actin polymerization inhibitor (Supplementary 
Fig. 8). However, as shown with the actin polymerization inhibitor 
blebbistatin, this compound fails to recapitulate the synergistic effect 
with TGF-β2, since unlike PKC activators, no activation of early response 
genes is achieved. Also of interest is that an EGR1 knockdown corre-
sponds strongly with the gene signature of a TGF-βR-II knockdown, 
further emphasizing the relationship between these genes 
Figure 4. Micro-topographies positively modulate TGF-β signaling. A-B) TGF-β2 treated MSCs exhibited the highest P-SMAD immunolabeling in the nucleus 
after 30 min when cultured on surface PS-1018 compared to flat. Scale bar represents 100 μm. C) TGF-β treatment induces elevated SCX expression already 4 h after 
cell seeding, while PS-1018 induces an observable increase after 8 h. Also at 8 h, improved SCX levels are observed when combining micro-topographies with TGF-β2. 
Peak SCX levels are reached at 24 h for all conditions. After 24 h, overall SCX levels drop. Micro-topographies however retain their synergistically effect when 
combined with TGF-β2 at 48 h, 72 h and 7 days. D) Synergistic effect on SCX expression induced by the micro-topography can be reproduced with dermal fibroblasts 
and the mouse mesenchymal stem cell line C3H10T1/2. E) Improved α-SMA expression is observed when combining both PS-1018 and TGF-β2 at 72 h and 7 days. F) 
Improved SOX9 expression is observed when combing PS-1018 and TGF-β2 at 48 h and 7 days (*P < 0.05; **P < 0.01; ***P < 0.001). Each asterisk represents 
statistical significance of SCX expression levels compared to a flat control condition unless otherwise indicated. Barplots represent the mean with error bars rep-
resenting SEM. 
Figure 5. Mechanistic pathway scheme of how micro-topographies might 
induce a synergistic effect in the expression of TGF-β target genes. 
Included are the inhibitors used to block the activation of these pathways. 
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(Supplementary Fig. 9). 
From the PKC activator component list (Supplementary Fig. 10), 
ingenol and prostratin were added to MSCs with and without TGF-β2, 
and SCX levels were measured after 24 h. Without TGF-β2, ingenol and 
prostratin induced similar SCX levels as the PS-1018 surface (Fig. 7F). In 
the presence of TGF-β2, prostratin induced a 36.2 fold SCX expression 
compared to a regular flat surface without TGF-β2. Ingenol-3 induced a 
similar response, with slightly higher SCX levels (39.1 fold change) than 
prostratin. No significant differences between the topography and PKC 
activators were observed when adding TGF-β2. These findings demon-
strate that PKC activators strikingly mimic the effect of the micro- 
topography in inducing SCX levels. 
In previous work, we found that tenocytes rapidly lose their 
phenotypic characteristics in cell culture [42]. This is characterized by 
the transformation of a spindle-shape morphology towards a spread-out 
morphology, coinciding with the formation of F-actin stress fibers. 
Furthermore, it is known that already during the initial in vitro culturing, 
tenogenic marker expression decreases, as shown for SCX [74]. We were 
therefore interested in investigating if PKC activators could improve 
phenotypic characteristics in tenocyte culture. Therefore, we treated 
passage one tenocytes with- and without the PKC activators and TGF-β2 
and found more profound spindle-shaped characteristics in confluent 
conditions when cells were treated with ingenol, both without and with 
TGF-β2 (Fig. 8A). To further investigate their morphological charac-
teristics, we fixed cells 72 h after adding the compounds and stained for 
F-actin, and SCX. Ingenol caused an apparent reduction in F-actin stress 
fibers and a decrease in F-actin intensity levels (Fig. 8B). Of interest is 
that TGF-β2 induces a more spread out morphology, which coincided 
with higher F-actin levels. This observation was also abolished by 
ingenol. We found that TGF-β2 was able to increase SCX levels, which 
could be further amplified by the ingenol treatment (Fig. 8C). These 
novel findings demonstrate that PKC activators replace the synergistic 
effects of the micro-topography both in the context of TGF-β induced 
MSC differentiation and phenotypic maintenance of tenocytes. 
3. Discussion 
We present evidence that TGF-β signaling is positively modulated 
through mechano-induced topographical cues. This work emphasizes 
the importance of recapitulating the crosstalk typically seen in vivo be-
tween mechanical and soluble cues in an in vitro culture setting. In 
addition, the results of this work put other research from the tissue- 
engineering field in a new perspective. BMP-2 is a growth factor that 
improves bone formation in a clinical setting, but only at un- 
physiologically high levels of the protein [75]. We hypothesize that 
BMP-2 is presented in the wrong mechanical context, and mechanical 
fine-tuning can lead towards greater efficacy. Research combining 
BMP-2 with mechanical loading indeed seems to indicate this [76]. 
Similarly, VEGF promotes angiogenesis, yet it also leads to vascular 
disruption [77]. Here it is plausible that the underlying mechanisms will 
Figure 6. Pathway inhibitors reveal 
that micro-topographical induced 
SCX expression requires Rho/ROCK/ 
SRF signaling. A) DMSO does not affect 
SCX levels in each condition. B) In-
hibitors against the TGF-β receptor 
abolish SCX levels on all conditions 
including PS-1018, emphasizing the 
involvement of TGF-β signaling for 
micro-topographical induction of SCX. 
C-E) The Rho/ROCK/SRF inhibitors 
Y27632, CCG-209371, and blebbistatin 
abolishes the topography-induced effect 
on SCX expression. F) The MAPK/MEK 
inhibitor U0216 reduces overall SCX 
expression, yet does not reduce the 
synergistic effect on SCX expression (ns 
= non-significant; *P < 0.05; ***P <
0.001). Each asterisk represents statis-
tical significance of SCX expression 
levels compared to a flat control condi-
tion unless otherwise indicated. Bar-
plots represent the mean with error bars 
representing SEM.   
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be better controlled by implementing alternative stimulation as well. It 
is therefore interesting to reconsider growth factor-mediated cell dif-
ferentiation and cell growth in the context of biomechanical conditions. 
In an in vitro context, other studies involving geometrical-induced 
modulation of tenogenic gene expression do not consider the potential 
synergistic effects of growth factor signaling in their experimental setup 
[42,78–82]. An exception is a study documenting improved SCX 
expression in a dermal fibroblast culture on micro-grooves combined 
with TGF-β1 [83]. Besides micro-topographies, other physical cues such 
as scaffolds enhance tenogenic characteristics of MSCs and progenitor 
cells [84,85], making this also an interesting material design for 
exploring if they modulate TGF-β signaling. In this context, matrix 
stiffness can influence SCX expression [86], another physical parameter 
known for modulating TGF-β signaling [87–89]. Our setup involving 
micro-topographies and TGF-β2 allowed for a strong induction in SCX 
expression compared to solely changing the material parameters, or the 
addition of TGF-β [26]. Additional research will however be required to 
determine if this combined setup induces true tenogenesis in MSCs by 
profiling their gene expression and comparing this with that of teno-
cytes. Since the biomechanical stimulation that the micro-topographies 
exert on SCX expression and other TGF-β target genes is transient, it 
might in the future be interesting to introduce TGF-β in a culture system 
with a combination of both micro-topographies and mechanical 
stretching [90,91], of which the latter improves tenogenesis in MSCs as 
well [92,93]. These examples highlight the potential of future research 
involving biomaterials that investigate interactions with TGF-β signaling 
in a tissue-engineering context. 
In this study, we found mechanobiological signaling similarities with 
other experimental setups. For example, increased levels of EGR1 during 
the cell adaptation phase are also found early upon cell stretching 
together with increased levels of FOS [32]. EGR1 plays a crucial role in 
tenocyte mechanical signaling and can influence TGF-βR-II [52], SCX, 
and other tenogenic markers [49–51]. It is therefore not surprising that 
mechanical stimulation through stretching is studied extensively for 
inducing MSC differentiation [92,94], and tenogenic matrix deposition 
[95]. Furthermore, a clear link exists between mechanical forces and 
TGF-β/SMAD activation in numerous cell types [93,96,97]. SRF activity 
plays a central role in mediating actin dynamics [14,98], which is 
clearly altered and dynamically modulated by physical cues in this 
study. A plausible scenario is that SRF binds to serum response elements 
(SRE) in its promotor and those of FOS [47] and EGR1 [99], triggering 
the biological events we observe. This concept is further emphasized 
through the use of PKC activators, known to induce SRE activation [72], 
and thereby mimicking the effect of the topography. Although physical 
cues can regulate Rho/ROCK signaling [19], evidence points towards 
SRF as a subsequent and essential mediator in the observed biome-
chanical signaling events [22,24,25]. Also, experimental readouts that 
involve mechanical stretching can be blocked by inhibiting the Rho/R-
OCK/SRF pathway [100,101]. Related to this, the concept that SRF is 
involved in TGF-β signal transduction is not novel. Evidence exists that 
Figure 7. The L1000 connectivity map associates the gene signature of PKC activators with topography-induced mechanotransduction. A) ACTB knock-
down gene signature corresponds with a PKC activator score of 94.94. B) SRF knockdown gene signature corresponds with a PKC activator score of 95.69. C) FOS 
knockdown gene signature corresponds with a PKC activator score of 88.48. D) PKC perturbagen class gene signature corresponds with a MEK inhibitor score of 
− 98.08. E) Schematic overview representing phenotypical similarities between micro-topographies and PKC activators. F) Through qPCR, we found that the PKC 
activators prostratin and ingenol reproduce the micro-topographical effect on SCX expression, both with- and without the addition of TGF-β2 (*P < 0.05; **P < 0.01; 
***P < 0.001). Each asterisk represents statistical significance of SCX expression levels compared to a flat control condition unless otherwise indicated. Barplots 
represent the mean with error bars representing SEM. 
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force-induced activation of α-SMA and subsequent fibrosis is blocked by 
inhibiting the Rho/ROCK pathway and subsequent SRF activity [17, 
102]. 
This research provides novel insights into how physical cues transmit 
mechanobiological signaling. Especially the dynamical nature of the 
signaling cascades elicited by the micro-topographies is interesting. 
Parts of the mechanisms behind the phenomena we observe are however 
still unknown. For example, we do not rule out that FOS plays a role in 
TGF-β sensitization due to a binding affinity against SMAD2/3 [53]. 
Also, despite the apparent requirement of SRF for inducing TGF-β 
Figure 8. PKC activators reduce F-actin and elevate SCX in tenocytes. A) Ingenol-3 induces elongated cell characteristics in confluent conditions. Furthermore, 
reduced F-actin levels in tenocytes both with- and without a TGF-β2 treatment are observed when treated with ingenol. Similar as shown with MSCs, SCX levels 
increase in tenocytes with PKC activator treatment. Scale bar represent 100 μm. B) F-actin immunolabeling quantification reveals significant lower levels when 
tenocytes are treated with ingenol, both with- and without TGF-β2. C) SCX immunolabeling quantification reveals significant increased levels when cells are treated 
with ingenol and TGF-β2, with a most optimal effect when combining both perturbations (***P < 0.001). Dotplots represent either F-actin intensity levels of in-
dividual cells, or SCX intensity levels of individual nuclei. Blue line indicates median. 
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sensitivity, other transcription factors might play a role in activating 
SRE’s of EGR1 and FOS in conjunction with SRF [103]. More insights 
will need to be gained by investigating how much pathway overlap there 
is between physical cues, PKC activation, and mechanical stretching. 
The observation that PKC activators mimic topography-induced 
biomechanical stimulation is a fascinating concept since it extends the 
translational perspectives of our experiments. Small molecules inducing 
the same synergistic effect as micro-topographies could be introduced 
into a clinical context where mechanical loading events typically sup-
port tissue repair. For tendon tissue-engineering, this implies the po-
tential to utilize PKC activators for stimulating a growth factor-mediated 
healing response, which might improve current clinical treatments 
[104]. 
4. Conclusion 
We demonstrate that micro-topographies influence TGF-β signaling 
in MSCs, leading to increased expression of the differentiation markers 
SCX, SOX9, and α-SMA. We connect the origin of this mechanobiological 
signaling with actin remodeling elicited by physical cues, which co-
incides with subsequent activation of early response genes associated 
with an upregulation of TGF-βR-II. Through extensive pathway analysis, 
we identify small molecule compounds that mimic the effect of the 
micro-topography. The results of this study can lead to improved pro-
tocols for the differentiation of MSCs or phenotypic maintenance of 
primary cells involving TGF-β signaling. Furthermore, the identification 
of small molecules that mimic mechanobiological stimulation might be 
applied in a clinical setting for replacing mechanical stimulation in 
conjunction with soluble cues. 
5. Materials and methods 
5.1. Surface fabrication 
A detailed description of the surface fabrication procedures is found 
elsewhere [105]. In short, the inverse pattern of the topographies was 
etched into a silicon wafer by directional reactive ion etching (DRIE). To 
facilitate demoulding procedures, the wafer was coated with a layer of 
Trichloro(1H,1H,2H,2H-perfluorooctyl)silane (FOTS, Sigma-Aldrich). 
Polydimethylsiloxane (PDMS; Down Corning) was cured on the silicon 
wafer to generate a positive mould and was subsequently used as a 
template to create a second negative mould in Ormostamp polymer 
(micro resist technology Gmbh), which serves as the mould for hot 
embossing the polystyrene (PS) films (Goodfellow). The hot embossing 
procedure was carried out at 140 ◦C for 5 min, and a pressure of 10 Bar, 
with a demoulding temperature of 90 ◦C. Before cell culture, the PS 
topographies were treated with oxygen plasma to improve cell adhesion 
for 30 s at 0.8 mbar, 50 sccm O2, and 100 W. Quality of the fabricated 
imprints was assessed using a Keyence VK-H1XM-131 profilometer. 
5.2. Cell culture 
Adipose-derived human mesenchymal stem cells (AD-hMSCs) and 
dermal fibroblasts (DF) used in this study were purchased from Lonza. 
AD-hMSCs and DF were isolated from a 42-year-old, and 27-year-old 
female respectively. C3H10T1/2 cells were purchased at ATCC. All 
methods were performed in accordance with the relevant ethical 
guidelines and regulations of the University of Maastricht. Basic medium 
for AD-hMSCs and DF consists of MEM Alpha GlutaMAX, no nucleosides 
(Gibco). For the culture of C3H10T1/2 cells, DMEM low glucose (Merck) 
was used as basic media. Basic media was supplemented with 10% v/v 
fetal bovine serum (FBS), 0.2 mM ascorbic-acid-2-phosphate (ASAP), 
and 10 U/mL Penicillin/Streptomycin. Cells were grown at 37 ◦C in a 
humid atmosphere at 5% CO2. For experimental purposes, cells at pas-
sage 3–4 were seeded at a density of 5000–10000 cells/cm2 on flat and 
the topographical surface. Human TGF-β2 (Peprotech), and mouse TGF- 
β2 (R&D Systems) were included in the media during cell seeding at a 
final concentration of 20 ng/ml. Pathway inhibitors blebbistatin, 
Y27632, CCG-203971, U2016, and SB431542 were purchased from 
Sigma-Aldrich and included in the media at a final concentration of 10 
μM. For inhibitor studies, inhibitors were added to the cell media 1 h 
prior and during cell seeding. PKC activators Ingenol, and Prostratin 
were purchased from Sigma-Aldrich, and added to the medium at a final 
concentration of 10 μM during cell seeding or media replacement. 
5.3. Microarray study and pathways analysis 
Bone marrow-derived human MSCs were seeded on topography PS- 
281 for 24 h in basic medium at a density of 15,000 cells/cm2 in 24 
well plates in three replicas. Total RNA was isolated using the Nucleo-
spin RNA isolation kit (Macherey–Nagel). Then, from 100 ng of RNA, 
cRNA was synthesized using the Illumina TotalPrep RNA amplification 
kit. Both RNA and cRNA quality was verified on a Bioanalyzer 2100 
(Agilent). Microarrays were performed using Illumina HT-12 v4 
expression Beadchips. 750 ng of cRNA was hybridized on the array 
overnight, after which the array was washed and blocked. Then, through 
the addition of streptavidin Cy-3, a fluorescent signal was developed. 
Arrays were scanned on an Illumina Beadarray reader, after which raw 
intensity values were background corrected in BeadStudio (Illumina). 
Further data processing and statistical testing were performed using the 
online portal arrayanalysis.org. The probe-level raw intensity values 
were quantile normalized and transformed using variance stabilization 
(VSN). A detection threshold of 0.01 was used for reducing the number 
of false positives. A linear modelling approach with empirical Bayesian 
methods, as implemented in Limma package, was applied for differential 
expression analysis of the resulting probe-level expression values. 
To construct a gene network of the DEGs, we applied an online 
STRING analysis (https://string-db.org/). Only DEG with a fold change 
higher than 1.5 and an adjusted p-value lower than 0.05 were included 
in the list. 
For identifying small molecules that mimic topography-induced 
pathways, we searched for relevant genes affected by the micro- 
topography in the connectivity map (https://clue.io/). 
5.4. Phospho proteomics study 
5.4.1. In-liquid digestion 
A total of 60 μg protein in 50 μl 50 mM ammonium bicarbonate 
(ABC) with 5 M urea was used. 5 μL of dithiothreitol (DTT) (20 mM final) 
was added and incubated at room temperature for 45 min. The proteins 
were alkylated by adding 6 μL of IAA solution (40 mM final). The re-
action was taken place at room temperature for 45 min in the darkness. 
The alkylation was stopped by adding 10 μL of DTT solution (to consume 
any unreacted IAA) and incubated at room temperature for 45 min. For 
the protease digestion, 2 μg trypsin/lysC was added to the protein and 
incubated at 37 ◦C for 2 h. 200 μl of 50 mM ABC was added to dilute the 
urea concentration and further incubate at 37 ◦C for 18 h. The digestion 
mix was centrifuge at 2 × 103 g for 5 min and the supernatant collected. 
Phospho-peptides were enriched by using TiO2 spin columns ac-
cording the manufacturers protocol (Thermo Scientific). Samples were 
subsequently labeled with TMT isobaric mass tagging labelling reagent 
(10-plex; Thermo Scientific) according to the manufacturer’s protocol. 
In short, 60 μg of protein for each sample was used. The TMT labelling 
reagents were dissolved in 41 μl acetonitrile per vial. The reduced and 
alkylated samples and control were added to the TMT reagent vials. The 
reaction was incubated for 1 h at room temperature and quenched for 
15 min by adding 8 μl of 5% hydroxylamine. Equal amounts of the 
samples and control were combined in a new vial and analyzed by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS). 
5.4.2. Protein identification using LC-MS/MS 
A nanoflow HPLC instrument (Dionex ultimate 3000) was coupled 
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on-line to a Q Exactive (Thermo Scientific) with a nano-electrospray Flex 
ion source (Proxeon). The final concentration of the TMT labeled digest/ 
peptide mixture was 0.33 μg/μl and 5 μl of this mixture was loaded onto 
a C18-reversed phase column (Thermo Scientific, Acclaim PepMap C18 
column, 75-μm inner diameter x 15 cm, 2-μm particle size). The peptides 
were separated with a 90 min linear gradient of 4–68% buffer B (80% 
acetonitrile and 0.08% formic acid) at a flow rate of 300 nL/min. 
MS data was acquired using a data-dependent top-10 method, 
dynamically choosing the most abundant precursor ions from the survey 
scan (280–1400 m/z) in positive mode. Survey scans were acquired at a 
resolution of 70 x 103and a maximum injection time of 120 ms. Dynamic 
exclusion duration was 30 s. Isolation of precursors was performed with 
a 1.8 m/z window and a maximum injection time of 200 ms. Resolution 
for HCD spectra was set to 30,000 and the Normalized Collision Energy 
was 32 eV. The under-fill ratio was defined as 1.0%. The instrument was 
run with peptide recognition mode enabled, but exclusion of singly 
charged and charge states of more than five. 
5.4.3. Database search 
The MS data were searched using Proteome Discoverer 2.2 Sequest 
HT search engine (Thermo Scientific), against the UniProt human 
database. The false discovery rate (FDR) was set to 0.01 for proteins and 
peptides, which had to have a minimum length of six amino acids. The 
precursor mass tolerance was set at 10 parts per million (ppm) and the 
fragment tolerance at 0.02 Da. One miss-cleavage was tolerated, Phos-
phorylation of serienes, tyrosines and threonines as well as oxidation of 
methionine were set as a dynamic modification. Carbamidomethylation 
of cysteines, Tandem mass tag (TMT) reagent adducts (+229.162932 
Da) on lysine and peptide amino termini were set as fixed modifications. 
5.5. Immunocytochemistry 
After cell culture, the cells were washed with phosphate buffered 
saline (PBS; Merck) and fixed with 4% (w∕v) paraformaldehyde (Sigma- 
Aldrich) for 5 min at 37 ◦C. After a washing step, cells were per-
meabilized with 0.01% (v/v) Triton X-100 (Acros Organics) and blocked 
with goat serum (1:100; Sigma-Aldrich) in PBT (PBS + 0.02% Triton-X- 
100, 0.5% BSA) for 1 h. Afterwards, cells were incubated with the pri-
mary antibody in PBT for 1 h. After a washing step, cells were incubated 
with a secondary antibody targeting the primary antibody protein of 
interest and conjugated to an Alexa Fluor (1:500; ThermoFisher) in PBT. 
After washing, the nucleus was counterstained with Hoechst 33258 
(1:1000; Sigma-Aldrich) for 10 min. After a subsequent washing step, 
surfaces were mounted on glass cover slides with mounting media 
(Dako). All washing steps were performed in triplicate with PBT. Pri-
mary antibodies used in this study are: anti-SCX antibody (1:200; 
Abcam; ab58655), anti-EGR1 antibody (1:200; ThermoFisher; T.126.1), 
anti- Phospho-Smad2/3 (1:200; Cell Signaling Technologies; 8828S), 
and anti-SRF antibody (1:200; Santa Cruz; sc-335). 
5.6. Image analysis 
Fixed samples were inverted and fluorescent images were acquired 
through the glass coverslip using a fully automated Nikon Eclipse Ti–U 
microscope in combination with an Andor Zyla 5.5 4 MP camera. 
Fluorescent images were analyzed through CellProfiler 3.1.8 [106] 
applying custom-made pipelines. All images were cropped in order to 
remove out-of-focus objects. Objects touching the border of the subse-
quent images were filtered out of the dataset. After illumination cor-
rections, morphology of the nucleus was captured by the Otsu adaptive 
thresholding method applied on the Hoechst 33258 image channel. 
Subsequently, cell morphology was determined by applying propagation 
and Otsu adaptive thresholding on the Phalloidin image channel. Mis-
segmentation artifacts were removed by applying an arbitrary threshold 
on nuclei and cell size. After background correction, intensity values of 
the target of interest were calculated either inside the nuclear or cell 
area. The image software Fiji was used for image visualization [107]. 
Brightness and contrast was equally adjusted between images of the 
same panel to enhance clarity. 
5.7. Quantitative polymerase chain reaction (qPCR) 
After cell lysis by Trizol (Thermo Fisher), total RNA was isolated 
using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s 
protocol. Reverse transcription was carried out using an iScript™ cDNA 
synthesis kit (Bio-Rad). Quantitative PCR was performed using the iQ™ 
SYBR® Green Supermix (Bio-Rad) in a CFX96 Touch Real-Time PCR 
Detection System (Bio-Rad). The software qBase + allowed determining 
relative expression using the ΔΔCt method. The geometric mean of the 
reference genes Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and TATA-Box Binding Protein (TBP) was applied for normalization. 
Primer sequences are listed in Supplementary Table 3. 
5.8. Statistical analysis 
Statistical analysis was performed with GraphPad Prism (GraphPad 
Prism Software Incl. San Diego, USA). For image analysis where more 
than two experimental conditions are considered, a two-way ANOVA 
was applied for determining statistical significance between conditions. 
Each data point represents a measurement from an individual cell. 
Image experiments were replicated with similar results. For image 
analysis with two experimental conditions, such as is the case for the P- 
SMAD data, a two-sided T-test was applied. For qPCR data, two-sided T- 
test statistics was applied for determining if the fold change of a con-
dition is significant different than the flat control. One-way ANOVA was 
applied for determining statistical significance of the fold changes be-
tween conditions. qPCR data is based on at least three independent ex-
periments, with each data points representing an independent 
experiment. Microarray P-values were corrected for multiple testing 
using the Benjamini and Hochberg method. Genes with a corrected p- 
value below 0.05 were considered differentially expressed. 
5.9. MSC osteogenic and adipogenic differentiation 
To assess if the AD-MSCs were multipotent during the experiments, 
we investigated their potential for differentiation towards the osteo-
genic and adipogenic lineage. Differentiation of AD-hMSCs towards the 
osteogenic lineage was achieved by seeding AD-hMSCs at a density of 5 
× 103 cells/cm2. After 24 h, medium was changed with either a control 
or mineralization medium. The mineralization media is basic media 
supplemented with 10% v/v fetal bovine serum (FBS), 10 U/mL Peni-
cillin/Streptomycin, with 10 nM dexamethasone (Sigma) and 10 mM 
β-glycerol phosphate (Sigma), while control medium includes the same 
components except dexamethasone. Media was refreshed every 2–3 days 
and after 21 days, cells were fixed overnight at 4 ◦C with 4% formal-
dehyde (VWR) in PBS. Afterwards, osteogenesis was assessed through 
staining mineralized deposits with a 2% Alizarin Red solution (pH = 4.2) 
for 2 min. Excess staining was washed off with demineralized water 
(Supplementary Fig. 11A). 
Differentiation of AD-hMSCs towards the adipogenic lineage was 
achieved by seeding AD-hMSCs at a density of 15 × 103 cells/cm2. After 
24 h, medium was replaced with either a control or adipogenic medium. 
The adipogenic media consist of basic media supplemented with 10% v/ 
v fetal bovine serum (FBS), 10 U/mL Penicillin/Streptomycin, 0.5 mM 3- 
isobutyl-1-methylxanthine (Sigma), 0.2 mM indomethacin (Sigma), 10 
μg/mL Insulin (Sigma), and 1 μM dexamethasone (Sigma). Control 
medium consisted solely of basic media with 10% v/v fetal bovine serum 
(FBS) and 10 U/mL Penicillin/Streptomycin. Media was refreshed every 
2–3 days and after 21 days, cells were fixed overnight at 4 ◦C with 3.7% 
formaldehyde (VWR), 0.01 g/ml CaCl2⋅2H2O (Merck) in PBS. After-
wards, adipogenesis was assessed by rinsing the fixation solution with 
demineralized water, and subsequently incubating the substrates in a 
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60% (v/v) 2-propanol (VWR) for 5 min. Fat droplets were stained 
through a freshly filtered solution of 0.3% (w/v) Oil Red O dissolved in 
60% (v/v) 2-propanol (VWR). Afterwards, the substrates were washed in 
triplicate with demineralized water (Supplementary Fig. 11B). 
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